Quick Answer
agilon health, inc. reported Net Income Loss of -$391.35 million for the year ending 2025.
- agilon health, inc. showed a decrease of -50.4% in Net Income Loss from 2024 to 2025.
- This data is from agilon health, inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$16.10 million | Q2 2020: -$7.91 million | Q3 2020: -$11.83 million | Q1 2021: -$15.08 million | Q2 2021: -$298.85 million | Q3 2021: -$35.84 million | Q1 2022: $1.23 million | Q2 2022: -$20.65 million | Q3 2022: -$30.67 million | Q1 2023: $16.02 million | Q2 2023: -$16.75 million | Q3 2023: -$31.44 million | Q1 2024: -$6.06 million | Q2 2024: -$30.68 million | Q3 2024: -$117.62 million | Q1 2025: $12.11 million | Q2 2025: -$104.37 million | Q3 2025: -$110.21 million.
- Over the full 7 years of available data (2019 to 2025), agilon health, inc.'s Net Income Loss has declined by 38.5%.
- Historical annual values: Fiscal year 2025: -$391.35 million | Fiscal year 2024: -$260.15 million | Fiscal year 2023: -$262.60 million | Fiscal year 2022: -$106.55 million | Fiscal year 2021: -$406.49 million | Fiscal year 2020: -$60.05 million | Fiscal year 2019: -$282.59 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: